Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral …

SD Chen, JH Yin, CS Hwang, CM Tang… - Free radical …, 2012 - Taylor & Francis
Sphingolipids represent a major class of lipids in which selected family members act as
bioactive molecules that control diverse cellular processes, such as proliferation …

Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: roles of Bcl-2 and thioredoxin

CM Tang, CS Hwang, SD Chen, DI Yang - Free Radical Biology and …, 2011 - Elsevier
In this study, we determined whether minocycline may protect rat cortical cultures against
neurotoxicity induced by sphingomyelinase/ceramide and explored the underlying …

Minocycline mediated mitochondrial cytoprotection: premises for therapy of cerebrovascular and neurodegenerative diseases

A Karachitos, J Solis Garcia del Pozo… - Current drug …, 2013 - ingentaconnect.com
In the last decades, emerging molecular targets for ischemic neuroprotection and
regeneration have been postulated. This fact allowed that classical drugs with well …

The mechanisms of minocycline in alleviating ischemic stroke damage and cerebral ischemia-reperfusion injury

K Zhao, P Wang, X Tang, N Chang, H Shi, L Guo… - European Journal of …, 2023 - Elsevier
Stroke is a group of diseases resulting from cerebral vascular rupture or obstruction and
subsequent brain blood circulation disorder, leading to rapid neurological deficits. Ischemic …

Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis

A Jana, K Pahan - Journal of Neuroimmune Pharmacology, 2007 - Springer
Multiple sclerosis (MS) is the most common human demyelinating disease of the central
nervous system where oxidative stress has been proposed to play an important role in …

Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons

S Lin, X Wei, Y Xu, C Yan, R Dodel, Y Zhang, J Liu… - Life sciences, 2003 - Elsevier
Neurotoxicity induced by 6-hydroxydopamine (6-OHDA) is believed to be due, in part, to the
production of reactive oxygen species (ROS). Anti-oxidants by inhibiting free radical …

Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease

M Thomas, WD Le, J Jankovic - Clinical neuropharmacology, 2003 - journals.lww.com
Remarkable progress has been made during the past decade in our understanding of
mechanisms of cell death in neurodegenerative disorders such as Parkinson's disease (PD) …

[HTML][HTML] The therapeutic role of minocycline in Parkinson's disease

S Cankaya, B Cankaya, U Kilic, E Kilic, B Yulug - Drugs in context, 2019 - ncbi.nlm.nih.gov
Minocycline, a semisynthetic tetracycline-derived antibiotic, has been shown to exert anti-
apoptotic, anti-inflammatory, and antioxidant effects. Furthermore, there is rapidly growing …

Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage

N Morimoto, M Shimazawa, T Yamashima, H Nagai… - Brain research, 2005 - Elsevier
The neuroprotective effects of minocycline–which is broadly protective in neurologic-disease
models featuring cell death and is being evaluated in clinical trials–were investigated both in …

Minocycline and cytoprotection: shedding new light on a shadowy controversy

J Jordan, FJ Fernandez-Gomez, M Ramos… - Current drug …, 2007 - ingentaconnect.com
In this review we explore and integrate the knowledge of the plausible pharmacological
targets that could explain the new application for the well known semi-synthetic, tetracycline …